Royce & Associates’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-35,460
| Closed | -$278K | – | 790 |
|
|
2025
Q1 | $278K | Hold |
35,460
| – | – | ﹤0.01% | 760 |
|
|
2024
Q4 | $373K | Hold |
35,460
| – | – | ﹤0.01% | 777 |
|
|
2024
Q3 | $465K | Hold |
35,460
| – | – | ﹤0.01% | 805 |
|
|
2024
Q2 | $499K | Sell |
35,460
-13,102
| -27% | -$184K | ﹤0.01% | 790 |
|
|
2024
Q1 | $820K | Buy |
48,562
+27,581
| +131% | +$466K | 0.01% | 746 |
|
|
2023
Q4 | $296K | Buy |
+20,981
| New | +$296K | ﹤0.01% | 825 |
|